A probiotic fermentation agent with alcohol sobering and liver protecting effects and its application
Through the combination of probiotic fermentation agent and Chinese medicine extract, ethanol dehydrogenase and acetaldehyde dehydrogenase are activated, which solves the liver burden caused by long-term drinking, significantly reduces the levels of ethanol, acetaldehyde, ALT and AST, and achieves understanding of alcohol and The dual effect of liver protection.
Patent Information
- Application Number
- CN202311255212.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-09-27
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2043-09-27
AI Technical Summary
Long-term drinking leads to increased liver burden, and the prior art is difficult to effectively reduce the levels of ethanol, acetaldehyde, ALT and AST, and lacks products that quickly hang up and long-term liver protection.
Probiotic fermentation agents such as Lacticaseibacillus rhamnosus MC-1, SSN-13 and Limosilactobacillus fermentum G-1-46 were prepared with fermentation in combination with Chinese medicine extract to prepare alcohol-relieving and protecting liver Functional fermentation Chinese herbal medicines and solid microecological preparations activate the enzyme activities of ethanol dehydrogenase and acetaldehyde dehydrogenase and improve antioxidant enzyme activities.
It significantly reduces the levels of ethanol, acetaldehyde, ALT and AST in the serum of mice, and has a protective effect on acute and chronic liver injury models, achieving the dual effects of understanding alcohol and protecting the liver.
Smart Images

Figure CN117487690B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a probiotic fermentation agent, in particular to a probiotic fermentation agent with alcohol sobering and liver protecting effects and application thereof. Background Art
[0002] Long-term drinking will increase the burden on the liver, causing mental disorders, gastric ulcers, fatty liver, alcoholic hepatitis, cirrhosis and other acute and chronic diseases. Among patients who drink alcohol for a long time, about 57.5% of patients have fatty liver and 15% have cirrhosis. The rising incidence of some digestive system tumors such as gastric cancer, esophageal cancer and liver cancer is also closely related to alcohol poisoning.
[0003] The human body's ability to excrete ethanol directly is relatively weak, and only 2% to 10% is excreted directly from the body through sweat, urine and other pathways. The vast majority relies on the liver for metabolism, and there are three main pathways, including: alcohol dehydrogenase system, microsomal alcohol oxidase system and catalase system. Through the above pathways, ethanol can be oxidized to acetaldehyde, and then oxidized to acetic acid by acetaldehyde dehydrogenase, and finally metabolized out of the body through the tricarboxylic acid cycle. This process can produce a large amount of NADH and acetaldehyde, which covalently bind to various proteins such as liver cell membrane proteins, CYP2E1, globulins and microsomal proteins to form acetaldehyde-protein adducts, which affect the enzyme activity in the body, cause fat metabolism disorders, aggravate the speed and degree of liver fatty degeneration and cause abnormal immune response. In recent years, with the improvement of people's material living standards, people have also paid more and more attention to their own health. In order to effectively reduce the occurrence of alcohol-related diseases and reduce the damage of alcohol to the liver, it is urgent to develop a mixed solid microecological preparation with medicinal and edible plants as raw materials and with the function of sobering up and protecting the liver. Summary of the invention
[0004] The technical problem to be solved by the present invention is to provide a probiotic fermentation agent with alcohol sobering and liver protecting effects and its application which can improve the enzyme activities of alcohol dehydrogenase and acetaldehyde dehydrogenase, reduce the levels of ethanol, acetaldehyde, ALT and AST in serum, and improve the activity of antioxidant enzymes.
[0005] The technical solution adopted by the present invention to solve the above technical problems is: a probiotic fermentation agent with alcohol sobering and liver protecting effects, wherein the probiotic fermentation agent comprises at least one of a Lactobacillus rhamnosus MC-1 strain, a Lactobacillus rhamnosus SSN-13 strain and a Lactobacillus fermentum G-1-46 strain, wherein the Lactobacillus rhamnosus MC-1 strain has a preservation number of CGMCC No: 27226, the Lactobacillus rhamnosus SSN-13 strain has a preservation number of CGMCC No: 27227, and the Lactobacillus fermentum G-1-46 strain has a preservation number of CGMCC No: 27225.
[0006] Furthermore, the preparation method of the probiotic fermentation agent is as follows: the rhamnosus lactobacillus MC-1, the rhamnosus lactobacillus SSN-13 and the fermented mucus lactobacillus G-1-46 are inoculated into the fermentation medium at a volume ratio of 5%, respectively, and cultured at 37°C for 18 hours to obtain a lactic acid bacteria culture, and the lactic acid bacteria cultures of rhamnosus lactobacillus MC-1, rhamnosus lactobacillus SSN-13 and fermented mucus lactobacillus G-1-46 are mixed at a volume ratio of 1:1:2.
[0007] Furthermore, the fermentation medium is prepared by dissolving MRS medium with 1L of distilled water and sterilizing at 121°C for 15 minutes. The formula of the MRS medium is 10 grams of peptone, 10 grams of beef extract, 5 grams of yeast extract, 2 grams of diammonium citrate, 5 grams of sodium acetate, 20 grams of glucose, 80 milliliters of Tween, 0.5 grams of magnesium sulfate, 0.25 grams of manganese sulfate and 15 grams of agar powder.
[0008] The above-mentioned probiotic fermentation agent is used to prepare a fermented Chinese medicinal drink with alcohol sobering and liver protecting functions, comprising the following steps:
[0009] (1) Preparation of Chinese herbal medicine extract: Weigh 15-20 g of Pueraria lobata flower, 20-25 g of Hovenia dulcis, 6 g of Atractylodes macrocephala, 6 g of Astragalus, 6 g of Lycium barbarum, 6 g of Dry ginger, 4.5 g of Poria, 6 g of Orientalis, 4.5 g of Ginseng, 3 g of Aucklandia lappa, 3 g of Citrus aurantium and 4.5 g of Citrus reticulata, fully crush the herbs with a wall-breaking machine, and pass through an 80-mesh sieve; add ultrapure water 10 times the volume of the Chinese herbal medicine powder to soak the Chinese herbal medicine powder, decoct for 1 hour, filter with gauze to remove large particles, centrifuge twice to obtain the supernatant, and sterilize at 121° C. for 15 minutes to obtain a Chinese herbal medicine extract;
[0010] (2) Fermentation: inoculating the probiotic fermentation agent into the Chinese medicine extract obtained in step (1) at a volume ratio of 4%, and fermenting at 37° C. for 48 hours to obtain a fermented Chinese medicine drink with alcohol sobering and liver protecting functions.
[0011] The above-mentioned probiotic fermentation agent is used to prepare a solid microecological preparation having the function of sobering up and protecting the liver, comprising the following steps:
[0012] (1) Preparation of Chinese herbal medicine extract: Weigh 15-20 g of Pueraria lobata flower, 20-25 g of Hovenia dulcis, 6 g of Atractylodes macrocephala, 6 g of Astragalus, 6 g of Lycium barbarum, 6 g of Dry ginger, 4.5 g of Poria, 6 g of Orientalis, 4.5 g of Ginseng, 3 g of Aucklandia lappa, 3 g of Citrus aurantium and 4.5 g of Citrus reticulata, fully crush the herbs with a wall-breaking machine, and pass through an 80-mesh sieve; add ultrapure water 10 times the volume of the Chinese herbal medicine powder to soak the Chinese herbal medicine powder, decoct for 1 hour, filter with gauze to remove large particles, centrifuge twice to obtain the supernatant, and sterilize at 121° C. for 15 minutes to obtain a Chinese herbal medicine extract;
[0013] (2) fermentation: inoculating the probiotic fermentation agent into the Chinese medicine extract obtained in step (1) at a volume ratio of 4%, and fermenting at 37° C. for 48 hours to obtain a fermented Chinese medicine drink;
[0014] (3) Preparation of lyophilized powder of fermented Chinese medicine: take the fermented Chinese medicine drink obtained in step (2), centrifuge it at 3000 rpm and 4°C for 15 min, take the supernatant and put it in a -80°C refrigerator for pre-freezing overnight, freeze-dry the pre-frozen sample at -49°C and 9Pa for 48 h to obtain lyophilized powder of fermented Chinese medicine;
[0015] (4) Preparation of lyophilized lactic acid bacteria powder: Take the lactic acid bacteria precipitate obtained after removing the supernatant in step (3), and adjust the bacterial concentration to 1×10 7 ~1×10 9 CFU / mL, centrifuge at 8000rpm and 4℃ for 15min, take the precipitate and add the freeze-drying protective agent of the same volume as the fermented Chinese medicine drink, mix well and put it into a -80℃ refrigerator for pre-freezing overnight, freeze-dry the pre-frozen sample at -49℃ and 9Pa for 48h to obtain the lactic acid bacteria freeze-dried powder;
[0016] (5) Preparation of solid microecological preparations
[0017] The fermented Chinese medicine freeze-dried powder prepared in step (3) and the lactic acid bacteria freeze-dried powder prepared in step (4) are mixed in equal amounts to obtain a solid microecological preparation having the function of sobering up and protecting the liver.
[0018] Furthermore, the freeze-drying protective agent formula is 118.2 g / L trehalose, 17.1 g / L L-cysteine, 10.3 g / L sorbitol, 1.7 g / L sodium acetate and 120 g / L skim milk powder.
[0019] Compared with the prior art, the advantages of the present invention are: a probiotic fermentation agent with the effects of sobering up and protecting the liver and its application, the fermented Chinese medicine drink obtained by using the probiotic fermentation agent and the solid microecological preparation are scientifically and reasonably compatible, can make full use of the functions of their various medicinal flavors, can effectively activate the enzyme activities of alcohol dehydrogenase and acetaldehyde dehydrogenase in the liver of mice, reduce the levels of ethanol, acetaldehyde, ALT and AST in serum, improve the activity of antioxidant enzymes, have obvious protective effects on the liver of mice in acute and chronic liver injury models, and fill the gap in the market for sobering up products with rapid sobering up and long-term liver protection.
[0020] The above-mentioned Lactobacillus rhamnosus MC-1 strain has a deposit number of CGMCC No: 27226. It was deposited on April 27, 2023 at the General Microbiology Center of the China Culture Collection Administration, and the deposit address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
[0021] The above-mentioned Lactobacillus rhamnosus SSN-13 strain has a deposit number of CGMCC No: 27227. It was deposited on April 27, 2023 at the General Microbiology Center of the China Culture Collection Administration, and the deposit address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
[0022] The above-mentioned fermentation mucus lactobacillus (Limosilactobacillusfermentum) G-1-46 strain has a preservation number of CGMCC No: 27225, and was deposited on April 27, 2023 at the General Microbiology Center of the China Culture Collection Administration, and the preservation address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 is the scavenging rate of lactic acid bacteria IC and CFE on hydroxyl free radicals. Note: The significant difference of IC of lactic acid bacteria complete cell suspension is indicated by lowercase letters; the significant difference of CFE of lactic acid bacteria cell-free extract is indicated by uppercase letters; Figure 2 is the scavenging rate of DPPH free radicals by lactic acid bacteria IC and CFE
[0024] Figure 3 is the scavenging rate of ABTS free radicals by lactic acid bacteria IC and CFE
[0025] Figure 4 are the growth curve and acid production curve of MC-1;
[0026] Figure 5 The growth curve and acid production curve of SSN-13;
[0027] Figure 6 The growth curve and acid production curve of G-1-46;
[0028] Figure 7 To simulate the survival rate of lactic acid bacteria in artificial gastric and intestinal fluids;
[0029] Figure 8 Electrophoresis of PCR products of strains G-1-46, MC-1 and SSN-1316S rDNA. Note: M: marker; Line 1: PCR product of G-1-14; Line 2: PCR product of MC-1; Line 3: PCR product of SSN-13;
[0030] Fig. 9 is the phylogenetic tree of strain G-1-46;
[0031] Fig.10 HE staining was performed on the liver of the acute intoxication model group of mice that consumed fermented Chinese medicine drinks;
[0032] Fig.11 HE staining was performed on the liver of the chronic drunkenness model group of mice that consumed fermented Chinese medicine drinks;
[0033] Fig.12 HE staining was performed on the liver of the acute intoxication model group of mice that consumed solid probiotic preparations;
[0034] Fig.13 HE staining was performed on the liver of the chronic alcoholic model group of mice that consumed solid probiotic preparations;
[0035] Fig.14 The bar chart shows the relative abundance of species at the genus level in the intestinal microorganisms of mice. Note: CG group represents the blank group; AG group represents the model group; LG group represents the low concentration group; MG group represents the medium concentration group; and MG group represents the high concentration group. DETAILED DESCRIPTION
[0036] The present invention is further described in detail below with reference to the accompanying drawings.
[0037] 1. Experimental Methods
[0038] 1. Culture medium and solution preparation
[0039] Fermentation medium: dissolve the purchased MRS medium (the formula of MRS medium is 10 g peptone, 10 g beef extract, 5 g yeast extract, 2 g diammonium citrate, 5 g sodium acetate, 20 g glucose, 80 ml Tween, 0.5 g magnesium sulfate, 0.25 g manganese sulfate and 15 g agar powder) in 1 L of distilled water and sterilize at 121°C for 15 min.
[0040] Solid culture medium: Add 15.0 g of agar to the fermentation medium and sterilize at 121°C for 15 min.
[0041] CaCO 3 Culture medium: Add 20.0 g of CaCO to the above solid MRS culture medium. 3 , sterilize at 121℃ for 15min.
[0042] Liquid screening medium: After the fermentation medium is sterilized, it is cooled to room temperature and 10% (v / v) anhydrous ethanol is added under sterile conditions for later use.
[0043] Artificial gastric juice: Accurately weigh 4.822 g NaCl powder and 3 g pepsin, add 1 L distilled water to dissolve, and adjust the pH value of the solution to 2 with dilute hydrochloric acid. Filter with a 0.22 μm filter membrane to ensure the sterility of the solution.
[0044] Artificial intestinal fluid: weigh 4.822 g NaCl, 7.233 g ox bile salts and 3 g trypsin, add 1 L distilled water to dissolve, adjust the pH value of the solution to 8 with NaOH, and filter with a 0.22 μm filter membrane under sterile conditions.
[0045] 2. Activation and preservation of strains
[0046] Select 2 mL of the strain stored in a -80°C refrigerator, inoculate it into 50 mL of fermentation medium, and culture it at 37°C for 12 hours to obtain the seed solution. Spread the seed solution for culture, observe the colony morphology, and place it upside down in a -4°C refrigerator for later use.
[0047] 3. Determination of ethanol resistance
[0048] In the blank group, 1 mL of seed liquid was inoculated into 50 mL of fermentation medium, cultured at 37°C for 12 hours, and the absorbance value Ac of the bacterial liquid at 600 nm was measured. The experimental group was operated in the same way as the blank group, but the seed liquid was inoculated into 50 mL of liquid screening medium, and the absorbance value was recorded as Ai. By comparing the absorbance values, the strains with better tolerance to ethanol were determined. The calculation formula is as follows:
[0049]
[0050] 4. Preparation of lactic acid bacteria solution
[0051] Lactic acid bacteria culture: The seed liquid of ethanol-tolerant lactic acid bacteria was inoculated into the fermentation medium, cultured at 37° C. for 18 h, and activated for three generations to obtain a lactic acid bacteria culture.
[0052] Lactobacillus complete cell suspension (IC): Take the lactic acid bacteria culture, centrifuge at 4000 rpm and 4°C for 15 min, remove the supernatant, wash twice with sterile PBS, resuspend the cells, and adjust the bacterial concentration to 1×10 8 CFU / mL.
[0053] Cell-free extract (CFE): The obtained lactic acid bacteria complete cell suspension was placed in an ice bath at 200W, ultrasonicated for 5s, with an interval of 5s, for a total of 15 minutes. Then, it was centrifuged at 4°C and 8000rpm for 15 minutes, and the supernatant was collected as the lactic acid bacteria liquid CFE.
[0054] 5. Determination of hydroxyl radical scavenging ability (·OH)
[0055] The scavenging rate of ·OH free radicals by lactic acid bacteria was calculated according to formula (2): where Ai is the absorbance of the sample group and Ac is the absorbance of the blank group.
[0056]
[0057] 6. Determination of DPPH free radical scavenging ability
[0058] The scavenging rate of DPPH free radicals by lactic acid bacteria was calculated according to formula (3), where Ai was the absorbance of the sample group and Ac was the absorbance of the blank group.
[0059]
[0060] 7. Determination of ABTS free radical scavenging ability
[0061] The scavenging rate of ABTS free radicals by lactic acid bacteria was calculated according to formula (4), where Ai is the absorbance of the sample group and Ac is the absorbance of the blank group.
[0062]
[0063] 8. Determination of digestion resistance
[0064] Take 20 mL of lactic acid bacteria culture medium that has been cultured for 18 h and adjust the bacterial concentration to 1×10 8CFU / mL, centrifuge 10mL of the bacterial solution with adjusted bacterial concentration (4℃, 6000rpm, 15min), remove the supernatant, add 10mL of artificial gastric juice to the bacteria, and incubate in a shaker at 37℃ and 120rpm for 2h. After incubation, take 1mL of the bacterial solution containing gastric juice for standard dilution and spread on MRS solid culture medium. Centrifuge the remaining bacterial solution containing gastric juice (4℃, 6000rpm, 15min), add 9mL of artificial intestinal juice to the obtained bacteria, culture in a shaker at 37℃ and 120rpm for 4h, dilute and spread on MRS solid culture medium. The control group is to adjust the bacterial concentration but not digested by artificial gastric juice and artificial intestinal juice, incubate in a shaker at 37℃ and 120rpm, and take the bacterial solution for dilution and coating after incubation for 2h and 6h respectively. The coated culture medium is cultured at 37℃ and the number of colonies is recorded. The acid resistance and bile resistance of lactic acid bacteria are calculated according to formulas (5) and (6):
[0065]
[0066]
[0067] Where Ax is the number of live bacteria contained in the bacterial solution after incubation in artificial gastric fluid for 2 hours; Ao is the number of live bacteria contained in the bacterial solution that has not been incubated in artificial gastric fluid for 2 hours; Ay is the number of live bacteria contained in the bacterial solution after incubation in artificial intestinal fluid for 4 hours; Ai is the number of live bacteria contained in the bacterial solution that has not been incubated in artificial intestinal fluid for 4 hours.
[0068] 9. Determination of growth curve and acid production curve
[0069] After the seed solution was activated for three generations, it was inoculated and cultured at an inoculum volume of 2% (v / v), and the pH value and absorbance at 600 nm of the fermentation solution were measured every 2 hours. The culture solution was fully shaken before each measurement, and the measurement was repeated three times.
[0070] 10. 16S r DNA identification and evolutionary analysis of lactic acid bacteria
[0071] (1) DNA extraction
[0072] Take fresh bacterial liquid, centrifuge at 8000rpm for 1min, obtain bacterial cells, and extract total DNA of the strain using a kit.
[0073] (2) PCR amplification and product detection
[0074] Universal primers were used to amplify the 16S rRNA gene. The primer sequences are as follows:
[0075] Upstream primer 27F: 5′-AGAGTTTGATCCTGGCTCAG-3′;
[0076] Downstream primer 1495R: 5′-CTACGGCTACCTTGTTACGA-3′;
[0077] The PCR cycle parameters were: 94°C pre-denaturation for 5 min, 94°C denaturation for 1 min, 64°C annealing for 1 min, 72°C extension for 2 min, 4°C terminal extension for 10 min, 34 cycles. The amplified PCR products were subjected to nucleic acid electrophoresis and sent to Sangon Biotech Co., Ltd. for gene sequence detection.
[0078] (3) Phylogenetic tree
[0079] The obtained strain sequences were compared with 16S rDNA gene fragments on the NCBI website, and the 16S rDNA gene sequences of strains with high similarity were extracted. The phylogenetic tree was constructed using the software MEGAX 64.
[0080] (4) Data processing and statistical analysis
[0081] Each experiment was repeated 3 times, and GraphPad Prism 9.4.0 and SPSS19.0 were used to perform statistical analysis on the experimental data and draw patterns. The experimental results were presented in the form of mean ± standard deviation (mean ± SEM). One-Way ANOVA single-factor analysis of variance was used for significance analysis of multiple groups of data.
[0082] 2. Screening of strains
[0083] 1. Lactic acid bacteria screening
[0084] 100 lactic acid bacteria strains were randomly selected from the strain collection of the Animal Products Processing Laboratory of Ningbo University for ethanol tolerance experiments. Finally, 10 strains with good tolerance to ethanol were obtained. Their colony morphology was observed. The results are shown in Table 1.
[0085] Table 1 Ethanol tolerance and colony morphology of experimental strains
[0086]
[0087] 2. Determination of OH removal capacity
[0088] Hydroxyl free radicals are a type of active oxygen, widely considered to be a highly toxic free radical. They react with adjacent molecules in a diffusion-controlled manner, have low specificity, and can react chemically with active substances such as DNA, phospholipids, and proteins contained in organisms very quickly, destroying the normal structure and function of cells and tissues. After alcohol enters the human body, it rapidly increases the level of hydroxyl free radicals in the body through oxidation by various metabolic enzymes in the body, affecting the body's health level.
[0089] The experiment tested the ability of lactic acid bacteria complete cell suspension IC and lactic acid bacteria cell-free extract CFE to scavenging hydroxyl free radicals. Figure 1 As shown. The IC and CFE of the above 10 lactic acid bacteria strains can scavenge hydroxyl free radicals to a certain extent. Among them, G-1-46 in the IC group has the strongest hydroxyl free radical scavenging ability, while the CFE of strains SSN-1 and 45-5 have better hydroxyl free radical scavenging ability.
[0090] 3. Determination of DPPH scavenging ability
[0091] Determination of scavenging rate of DPPH free radicals by 10 lactic acid bacteria strains IC and CFE Figure 2 As shown in the figure, the IC of strain B-1-12 has the strongest scavenging ability of DPPH free radicals, and the scavenging ability of CFE of strain B-1-12 and strain G-1-46 on DPPH free radicals is significantly higher than that of other groups (p < 0.05).
[0092] 4. Determination of ABTS removal ability
[0093] The ability of 10 lactic acid bacteria strains IC and CFE to scavenge ABTS free radicals Figure 3 The scavenging rate of ABTS free radicals by IC of strain SSN-13 was significantly higher than that of other groups (p < 0.05), and the scavenging rate of ABTS free radicals by CFE of strain MC-1 was significantly higher than that of other groups (p < 0.05), and the scavenging ability of IC of all strains was higher than that of CFE.
[0094] 5. Growth curve and acid production curve
[0095] After comprehensively comparing the ability of different lactic acid bacteria to clear the above three free radicals, we finally chose to use strains MC-1 and SSN-13 screened from fermented milk and strain G-1-46 screened from the intestines of a 3-year-old girl for subsequent experiments.
[0096] The growth curves of lactic acid bacteria strains MC-1, SSN-13 and G-1-46 with potential probiotic properties are shown in Figure 2 Figure 4 , Figure 5 and Figure 6 .Depend on Figure 4 and Figure 5 It can be seen that the OD of strains MC-1 and SSN-13 increased from 0h to 3h. 600 The value did not change much, the curve was relatively flat, and the pH value did not change. From 3h to 11h, the OD of the two lactic acid bacteria 600 The value showed a rapid upward trend, and the pH value of the bacterial solution also dropped rapidly. From 11h to 24h, OD 600 The value changes slowly, and the pH value decreases steadily. Figure 6It can be seen that the OD of strain G-1-46 from 0h to 2h 600 From 2h to 8h, the OD of the strain 600 The value rose rapidly, and the pH value of the bacterial solution also dropped rapidly. After 8h, OD 600 The values increased steadily, while the pH value remained basically stable with a slight decrease.
[0097] 6. Digestion resistance test results
[0098] To ensure that the microecological functional preparation has the function of sobering up and protecting the liver, a sufficient number of live bacteria must be digested by the stomach and enter the intestines. Figure 7 It can be seen that the above three lactic acid bacteria have good tolerance to artificial gastric juice and artificial intestinal juice. After 2 hours of artificial gastric juice treatment, the number of live bacteria of the strains decreased. Among them, the G-1-46 strain screened from the healthy human intestine has the best tolerance to artificial gastric juice, with a survival rate of 95.83%. MC-1 and SSN-13 have similar tolerance to artificial gastric juice, which are 80.73% and 77.43% respectively. After the tolerance test of simulated artificial gastric juice, the simulated artificial intestinal juice tolerance test was carried out. The data are as follows Figure 7 As shown, similar to the results of the simulated artificial gastric fluid test, G-1-46 also has the best tolerance to artificial intestinal fluid, with a survival rate of 86.72%, MC-1 has the lowest survival rate of 60.13%, and SSN-13 has a survival rate of 67.58%.
[0099] 7. Identification results of lactic acid bacteria strains
[0100] (1) Amplification of 16S rDNA of lactic acid bacteria isolates
[0101] Gel electrophoresis results of PCR amplification products, such as Figure 8 As shown, the product has no degradation, no tailing, good integrity, and meets the requirements for testing. The left side of the picture is the DNA marker, with a maximum of 8000bp, and the other three columns from left to right are strains G-1-46, MC-1, and SSN-13.
[0102] (2) Phylogenetic tree and homology analysis
[0103] The phylogenetic trees of strains MC-1, SSN-13, and G-1-46 are shown in Fig. 9 , it can be seen from the figure that strains MC-1 and SSN-13 are Lactobacillus rhamnosus, and G-1-46 is Lactobacillus fermentum.
[0104] In summary, 100 lactic acid bacteria were randomly selected from the Ningbo bacterial strain library for screening, and 10 lactic acid bacteria strains with significant tolerance to high concentrations of ethanol were obtained. On this basis, using a variety of in vitro antioxidant capacity detection indicators, including the level of scavenging hydroxyl radicals, DPPH radicals and ABTS radicals, three lactic acid bacteria strains with excellent antioxidant properties were identified, namely MC-1, SSN-13 and G-1-46.
[0105] The above three strains have excellent tolerance to artificial gastric juice and artificial intestinal juice, among which strain G-1-46 has the best tolerance, with a survival rate of 86.72% after the experiment. The survival rates of strains MC-1 and SSN-13 are 60.13% and 67.58%, respectively. The growth curve and acid production curve show that the three strains can grow rapidly and stably produce acid, enter the exponential growth phase after 2 hours, and have a long stable phase, with good growth stability. Through 16S rDNA sequencing identification, strains MC-1 and SSN-13 were determined to be Lactobacillus rhamnosus, and G-1-46 was determined to be Limosilactobacillus fermentum.
[0106] The above-mentioned Lactobacillus rhamnosus MC-1 strain has a deposit number of CGMCC No: 27226. It was deposited on April 27, 2023 at the General Microbiology Center of the China Culture Collection Administration, and the deposit address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
[0107] The above-mentioned Lactobacillus rhamnosus SSN-13 strain has a deposit number of CGMCC No: 27227. It was deposited on April 27, 2023 at the General Microbiology Center of the China Culture Collection Administration, and the deposit address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
[0108] The above-mentioned fermentation mucus lactobacillus (Limosilactobacillusfermentum) G-1-46 strain has a preservation number of CGMCC No: 27225, and was deposited on April 27, 2023 at the General Microbiology Center of the China Culture Collection Administration, and the preservation address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
[0109] 3. Determination of the optimal ratio of strains
[0110] Effects of different fermentation strains and ratios on the total antioxidant capacity of fermented Chinese herbal medicine products
[0111] Preparation of Chinese medicine extract: Weigh 15g of Pueraria lobata flower, 20g of Hovenia dulcis, 6g of Atractylodes macrocephala, 6g of Astragalus membranaceus, 6g of Lycium barbarum, 6g of Dry ginger, 4.5g of Poria cocos, 6g of Alisma orientalis, 4.5g of Ginseng, 3g of Aucklandia lappa, 3g of Citrus aurantium and 4.5g of Citrus reticulata, fully crush the medicinal materials with a wall breaking machine, and pass through an 80-mesh sieve; add ultrapure water 10 times the volume of the Chinese medicine powder to soak the Chinese medicine powder, decoct for 1h, filter with gauze to remove large particles, centrifuge twice to obtain the supernatant, sterilize at 121°C for 15min, and obtain the Chinese medicine extract.
[0112] Single bacteria fermentation experiment: Take the cooled Chinese medicine extract, inoculate MC-1, SSN-13 and G-1-46 lactic acid bacteria culture at a volume ratio of 4%, and ferment at 37°C for 24 hours. After the fermentation, mix the fermentation liquid and measure the total antioxidant capacity. The preparation method of each lactic acid bacteria culture is as follows: take 1mL of activated Lactobacillus rhamnosus MC-1, Lactobacillus rhamnosus SSN-13 and fermented Lactobacillus mucosa G-1-46 and inoculate them into 20mL fermentation medium respectively, and culture at 37°C for 18 hours to obtain lactic acid bacteria culture.
[0113] Mixed fermentation experiment: Take the cooled Chinese medicine extract and inoculate a mixture of MC-1, SSN-13 and G-1-46 lactic acid bacteria cultures at an inoculation rate of 4%. The mixing ratios are shown in Table 2. Ferment at 37°C for 24 hours. After the fermentation is completed, mix the fermentation liquid and measure the total antioxidant capacity.
[0114] Table 2 Fermentation strains and their mixing ratios
[0115]
[0116] Take the fresh fermented Chinese medicine drink after fermentation and immediately use the kit to determine the total antioxidant value of the solution. The experimental process strictly follows the requirements of the kit and draws a standard curve for determining the total antioxidant capacity. The single-strain and mixed-strain fermentations were performed using strains MC-1, SSN-13 and G-1-46. Under the same fermentation conditions, their antioxidant capacities are shown in Table 3.
[0117] Table 3 Effects of different fermentation strains and their ratios on total antioxidant capacity
[0118]
[0119] As shown in Table 3 above, all experimental strains can improve the total antioxidant value of Chinese medicine extracts by fermentation. However, when strains MC-1, SSN-13 and G-1-46 were mixed in a volume ratio of 1:1:2, with an inoculation volume of 4%, and fermented at 37°C for 24 hours, the total antioxidant capacity was the strongest, which was 39% higher than that of the unfermented Chinese medicine extract. Therefore, a bacterial suspension mixed with the fermentation culture of strains MC-1, SSN-13 and G-1-46 in a volume ratio of 1:1:2 was selected as a probiotic fermentation agent for subsequent experiments.
[0120] 4. Product application example 1 1. Specific embodiments
[0122] Example 1
[0123] A method for preparing a fermented Chinese medicinal drink for sobering up and protecting the liver comprises the following steps:
[0124] 1. Preparation of Chinese medicine extract: weigh 15g of Pueraria lobata flower, 20g of Hovenia dulcis, 6g of Atractylodes macrocephala, 6g of Astragalus, 6g of Lycium barbarum, 6g of Dry ginger, 4.5g of Poria, 6g of Orientalis, 4.5g of Ginseng, 3g of Aucklandia lappa, 3g of Citrus aurantium and 4.5g of Citrus reticulata, fully crush the medicinal materials with a wall-breaking machine, and pass through an 80-mesh sieve; add ultrapure water 10 times the volume of the Chinese medicine powder to soak the Chinese medicine powder, decoct for 1h, filter with gauze to remove large particles, centrifuge twice to obtain the supernatant, sterilize at 121°C for 15min, and obtain the Chinese medicine extract;
[0125] 2. Fermentation: inoculate the probiotic fermentation agent into the Chinese medicine extract obtained in step 1 at a volume ratio of 4%, and ferment at 37° C. for 48 hours to obtain a fermented Chinese medicine drink.
[0126] Example 2
[0127] The same as the above-mentioned Example 1, except that in the preparation step of the traditional Chinese medicine extract: weigh 20g of Pueraria lobata flower, 15g of Hovenia dulcis, 6g of Atractylodes macrocephala, 6g of Astragalus, 6g of Lycium barbarum, 6g of Dry ginger, 4.5g of Poria, 6g of Alisma orientalis, 4.5g of Ginseng, 3g of Costus root, 3g of Citrus aurantium, and 4.5g of Citrus reticulata.
[0128] Example 3
[0129] The same as the above-mentioned Example 1, except that in the preparation step of the traditional Chinese medicine extract: weigh 18g of Pueraria lobata flower, 25g of Hovenia dulcis, 6g of Atractylodes macrocephala, 6g of Astragalus, 6g of Lycium barbarum, 6g of Dry ginger, 4.5g of Poria, 6g of Alisma orientalis, 4.5g of Ginseng, 3g of Costus root, 3g of Citrus aurantium, and 4.5g of Citrus reticulata.
[0130] 2. Effect of fermentation on active ingredients in Chinese herbal medicine extracts
[0131] 1) Experimental plan: Use non-targeted metabolomics to analyze the differential metabolites of Chinese herbal medicine extracts before and after fermentation (Chinese herbal medicine extracts and fermented Chinese herbal medicine drinks);
[0132] 2) Experimental results: A total of 93 significantly changed differential metabolites were identified, including 11 sugars, 27 organic acids, 10 amino acids, 4 phenols, 9 ketones, 9 aldehydes, 9 nucleosides, 6 glycosides, vitamins, inorganic salts, etc., as shown in Table 4.
[0133] Table 4 Significant changes in metabolites before and after fermentation
[0134] name Difference multiple Flow rate (m / z) VIP Value Methyl cinnamate 4.309 163.075 1.607 Valine 1.933 118.086 2.795 Ornithine 32.021 133.097 2.130 Aspartic acid 1.461 132.030 1.058 Biochanin A 1.859 283.061 1.414
[0135] As shown in Table 4, the contents of methyl cinnamate, biochanin A, L-ornithine, D-Aspartic acid and valine in the fermentation broth increased significantly. Biochanin A is an oxidized methylated isoflavone compound, and its content increased significantly after fermentation. The molecular structure of biochanin A is similar to that of animal estrogen, so it can competitively bind to estrogen receptors and play an estrogen-like role. Biochanin A can upregulate the expression of cholesterol 7α-hydroxylase (CYP7A1) and low-density lipoprotein receptor (LDLR) in mouse liver, inhibit the production of sterol regulatory element binding protein (SREBP)-1c and the activation of peroxisome proliferator-activated receptor (PPAR)-γ, promote cholesterol absorption and excretion, and thus regulate liver lipid metabolism. Biochanin A can also regulate the NfκB pathway and the Nrf2 pathway and inhibit the activation of inflammasomes. In ALD patients, elevated blood ammonia is a characteristic of hepatocellular dysfunction, which further aggravates hepatocellular damage. L-ornithine can reduce ammonia levels in the liver, thereby effectively inhibiting liver damage indicators such as ALT and AST. It can also reduce central lobe cell death, hepatocyte expansion, inflammatory cell infiltration and necrosis. Valine can improve intestinal villus morphology, strengthen the intestinal barrier, and reduce the number of pathogenic bacteria in the cecum, thereby effectively reducing LPS leakage. In addition, the solution is rich in methyl cinnamate, which can improve the antioxidant capacity of mouse liver, duodenum and colon, and reduce alcohol damage to the liver.
[0136] 3. The effect of fermented Chinese medicine on the sobering and liver-protecting of mice with acute drunkenness model
[0137] 1) Experimental materials: SPF-grade healthy male C57BL / 6N mice, weighing approximately 20.00±2g / mouse, provided by the Experimental Animal Center of Ningbo University.
[0138] 2) Experimental plan: 30 mice were randomly divided into 6 groups: blank group, model group, positive group, and experimental group. The whole experimental process can be divided into two stages: intervention period (Day 1-8) and modeling period (Day 8-9). In the intervention period (Day 1-8), the blank group and model group mice were gavaged with sterile PBS, the positive group was gavaged with silymarin 100mg / (kg bw), and the experimental group was gavaged with fermented Chinese medicine. Gavage was performed once a day at a fixed time, and each mouse was gavaged with 15mL / kg of the corresponding solution each time for 7 consecutive days. The eighth day of the experiment was the modeling period. First, each group was gavaged with the corresponding solution. After 1 hour, except for the blank group, the remaining groups were gavaged with 50% (v / v) alcohol 15mL / kg for 3 consecutive times, with an interval of 12h each time. After the last alcohol gavage, the mice were fasted but not watered for 1.5h, and the mice were weighed and the corresponding serum and liver samples were collected. The kit was used to determine the ethanol and acetaldehyde contents in the mouse serum, the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and the enzyme activities of alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) in the liver, and the mouse liver was stained with HE.
[0139] 3) Experimental results: HE staining of mouse liver is as follows Fig.10 As shown, the results Fig.10 It can be seen that the liver cells of the blank group mice have complete structure and are tightly arranged, without obvious inflammatory cells and other histological abnormalities. The mice in the MG group had severe liver damage characteristics, but after being treated with the alcohol-relieving and liver-protecting Chinese medicine drink, the mouse liver cells were relatively intact and neatly arranged along the hepatic cords. Although some lipid droplets and nuclear dissolution occurred, the nuclei of most liver cells were still clearly visible. The test results are shown in Table 5 below. Table 5 Effects of the alcohol-relieving and liver-protecting Chinese medicine drink on the acute drunken mouse model
[0140]
[0141]
[0142] Note: *, significant difference (P<0.05); **, extremely significant difference (P<0.01).
[0143] The ethanol content in the blood can reflect the severity of alcohol poisoning. To a certain extent, the activity of ALD and ALDH enzymes is closely related to the metabolic rate of alcohol. As shown in Table 5, after mice drank alcohol, the ethanol content in the serum increased significantly, and after being treated with alcohol-detoxifying and liver-protecting Chinese medicine, the ethanol content in the mouse serum decreased significantly. Acetaldehyde has a strong toxic effect on the human body. It can destroy the functionality and integrity of cells, induce liver inflammation, activate hepatic stellate cells, stimulate the production of collagen, accelerate chronic liver damage and liver fibrosis, and at the same time, emotional irritability, confusion, and uncontrolled limbs caused by drinking are mainly caused by acetaldehyde. As shown in Table 5, after being treated with alcohol-detoxifying and liver-protecting Chinese medicine, the acetaldehyde content in the mouse serum can be significantly reduced, achieving the effect of alcohol detoxification and liver protection.
[0144] The levels of ALT and AST in the serum of mice with acute alcoholic liver injury are shown in Table 5. Compared with the blank group, the levels of ALT and AST in the serum of mice in the model group were significantly increased. At the same time, compared with the model group, the levels of ALT and AST in the serum of mice treated with fermented Chinese medicine decoction were significantly decreased, which shows that the use of fermented Chinese medicine decoction to treat mice with acute alcoholic liver injury can reduce liver damage caused by alcohol and has a certain protective effect on the liver of mice.
[0145] 4. The effect of fermented Chinese herbal medicine on the detoxification and liver protection of chronic drunkenness model in mice
[0146] 1) Experimental materials: SPF-grade healthy male C57BL / 6N mice, weighing approximately 20.00±2g / mouse, provided by the Experimental Animal Center of Ningbo University.
[0147] 2) Experimental plan: 20 mice were randomly divided into 4 groups: blank group, model group, positive group, and experimental group. The experiment lasted for 8 weeks. In the first week of the experiment, in order to adapt the mice to liquid food, each group of mice was fed with Lieber DeCarli liquid feed without alcohol. Starting from the second week, except for the blank group, the other groups were fed with Lieber DeCarli liquid feed containing ethanol. The ethanol concentration in the feed increased by 1% every three days until the ethanol concentration in the feed reached 3.73%, that is, Lieber DeCarli liquid feed containing 1% ethanol was fed on days 1-3, Lieber DeCarli liquid feed containing 2% ethanol was fed on days 4-6, Lieber DeCarli liquid feed containing 3% ethanol was fed on days 6-8, and Lieber DeCarli liquid feed containing 3.73% ethanol was fed on day 9 until the end of the experiment. During the experiment, each group of mice was gavaged at a fixed time every day, and the gavage conditions were the same as those of the acute liver injury model. After the last oral gavage, the mice were fasted but not watered for 12 hours, and serum and liver samples were collected from the mice. The levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the serum of the mice, and the levels of alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) in the liver were determined using a kit, and the liver of the mice was stained with HE.
[0148] 3) Experimental results: HE staining of mouse liver is as follows Fig.11 shown by Fig.11 It can be seen that the liver cells of the mice in the model group had chaotic boundaries, extensive edema, loose arrangement, and a large number of inflammatory cells infiltrated, which was consistent with the results of serum and liver homogenate related indicators. However, after being treated with the alcohol-relieving and liver-protecting Chinese medicine drink, the edema of the mouse liver cells was reduced, the integrity was enhanced, the cell nucleus was clearly visible, and the liver cord structure was clearer. The test results are shown in Table 6 below.
[0149] Table 6 Effects of alcohol-relieving and liver-protecting Chinese herbal medicine on the chronic drunkenness mouse model
[0150] Group Blank group Model Group Positive group Experimental Group ADH (U / g) 2.58±0.48 <![CDATA[5.78±0.88 ** ]]> <![CDATA[7.62±0.87 ** ]]> <![CDATA[6.81±0.67 ** ]]> ALDH (U / g) 4.73±0.48 3.03±0.69 <![CDATA[5.56±0.79 ** ]]> <![CDATA[5.54±0.70 * ]]> ALT(U / L) 19.04±2.98 <![CDATA[39.00±4.71 ** ]]> <![CDATA[24.98±2.71 ** ]]> <![CDATA[24.91±3.38 ** ]]> AST(U / L) 35.31±2.35 56.34±6.82 <![CDATA[39.77±2.62 ** ]]> <![CDATA[47.88±3.18 * ]]>
[0151] Note: *, significant difference (P<0.05); **, extremely significant difference (P<0.01).
[0152] As shown in Table 6, after treatment with fermented Chinese medicine, the activities of alcohol dehydrogenase and acetaldehyde dehydrogenase in mice with chronic liver damage can be significantly increased, reducing the damage to the liver caused by alcohol. It can also reduce the levels of ALT and AST in the serum of mice. The above data prove that the alcohol-relieving and liver-protecting Chinese medicine drink can reduce chronic liver damage caused by alcohol and has a protective effect on the liver of mice.
[0153] 5. Product application example 2 1. Specific embodiments
[0155] Example 1
[0156] A method for preparing a solid microecological preparation having the effects of sobering up and protecting the liver, comprising the following steps:
[0157] 1. Preparation of Chinese medicine extract: weigh 15g of Pueraria lobata flower, 20g of Hovenia dulcis, 6g of Atractylodes macrocephala, 6g of Astragalus, 6g of Lycium barbarum, 6g of Dry ginger, 4.5g of Poria, 6g of Orientalis, 4.5g of Ginseng, 3g of Aucklandia lappa, 3g of Citrus aurantium and 4.5g of Citrus reticulata, fully crush the medicinal materials with a wall-breaking machine, and pass through an 80-mesh sieve; add ultrapure water 10 times the volume of the Chinese medicine powder to soak the Chinese medicine powder, decoct for 1h, filter with gauze to remove large particles, centrifuge twice to obtain the supernatant, sterilize at 121°C for 15min, and obtain the Chinese medicine extract;
[0158] 2. Fermentation: inoculate the probiotic fermentation agent into the Chinese medicine extract obtained in step 1 at a volume ratio of 4%, and ferment at 37° C. for 48 hours to obtain a fermented Chinese medicine drink;
[0159] 3. Preparation of lyophilized powder of fermented Chinese medicine: take the fermented Chinese medicine drink obtained in step 2, centrifuge it at 3000rpm and 4℃ for 15min, take the supernatant and put it into a -80℃ refrigerator for pre-freezing overnight, freeze-dry the pre-frozen sample at -49℃ and 9Pa for 48h to obtain the lyophilized powder of fermented Chinese medicine;
[0160] 4. Preparation of lyophilized lactic acid bacteria powder: Take the lactic acid bacteria precipitate obtained after removing the supernatant in step 3, and use sterile PBS buffer to adjust the bacterial concentration to 1×10 8 CFU / mL, centrifuge at 8000rpm, 4℃ for 15min, take the precipitate and add the same volume of freeze-dried protective agent as the fermented Chinese medicine drink, mix well and put into -80℃ refrigerator for pre-freezing overnight, freeze-dry the pre-frozen sample at -49℃, 9Pa for 48h, take out the sample, which is the freeze-dried powder of lactic acid bacteria. The freeze-dried protective agent formula is 118.2g / L trehalose, 17.1g / L L-cysteine, 10.3g / L sorbitol, 1.7g / L sodium acetate and 120g / L skim milk powder 5;
[0161] 5. Preparation of solid microecological preparations
[0162] After the fermented Chinese medicine freeze-dried powder obtained in step 3 and the lactic acid bacteria freeze-dried powder obtained in step 4 are mixed in equal quantities, a solid microecological preparation with alcohol sobering and liver protecting effects is obtained, which is named the solid microecological preparation medium concentration group.
[0163] Example 2
[0164] The same as the above-mentioned Example 1, except that: in step 4, the lactic acid bacteria precipitate was taken and the bacterial concentration was adjusted to 1×10 7CFU / mL, and the solid probiotic preparation finally prepared was named the solid probiotic preparation low concentration group.
[0165] Example 3
[0166] The same as the above-mentioned Example 1, except that: in step 4, the lactic acid bacteria precipitate was taken and the bacterial concentration was adjusted to 1×10 9 CFU / mL, and the solid probiotic preparation finally prepared was named solid probiotic preparation high concentration group.
[0167] Example 5
[0168] The same as the above-mentioned Example 1, except that in the preparation step of the traditional Chinese medicine extract: weigh 20g of Pueraria lobata flower, 15g of Hovenia dulcis, 6g of Atractylodes macrocephala, 6g of Astragalus, 6g of Lycium barbarum, 6g of Dry ginger, 4.5g of Poria, 6g of Alisma orientalis, 4.5g of Ginseng, 3g of Costus root, 3g of Citrus aurantium, and 4.5g of Citrus reticulata.
[0169] Example 6
[0170] The same as the above-mentioned Example 1, except that in the preparation step of the traditional Chinese medicine extract: weigh 18g of Pueraria lobata flower, 25g of Hovenia dulcis, 6g of Atractylodes macrocephala, 6g of Astragalus, 6g of Lycium barbarum, 6g of Dry ginger, 4.5g of Poria, 6g of Alisma orientalis, 4.5g of Ginseng, 3g of Costus root, 3g of Citrus aurantium, and 4.5g of Citrus reticulata.
[0171] 2. The sobering and liver-protecting effects of solid microecological preparations on the acute drunkenness model in mice
[0172] 1) Experimental materials: SPF-grade healthy male C57BL / 6N mice, weighing approximately 20.00±2g / mouse, provided by the Experimental Animal Center of Ningbo University.
[0173] 2) Experimental plan: 25 mice were randomly divided into 5 groups: blank group, model group, low concentration group, medium concentration group and high concentration group. The whole experimental process can be divided into two stages: intervention period (Day 1-7) and modeling period (Day 8). In the intervention period (Day 1-7), the blank group and model group mice were gavaged with sterile PBS, the positive group was gavaged with silymarin (100 mg / (kg bw)), and the low concentration group, medium concentration group and high concentration group were respectively low, medium and high concentration solid microecological preparations. Gavage once a day at a fixed time, each mouse was gavaged with 15 mL / kg of the corresponding solution each time for 7 consecutive days. The 8th day of the experiment was the modeling period. First, each group was gavaged with the corresponding solution. After 1 hour, except for the blank group, the other groups were gavaged with 50% (v / v) alcohol 15 mL / kg, and the mice were fasted but not watered for 1.5 hours. The mice were weighed and the corresponding serum and liver samples were collected. The kits were used to determine the ethanol and acetaldehyde contents, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in mouse serum, and alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) levels in liver, and HE staining was performed on mouse liver tissues.
[0174] 3) Experimental results: HE staining of mouse liver is as follows Fig.12 As shown by Fig.12 It can be seen that the liver cell structure of mice in the blank group is intact and the cell nucleus is clear. The liver cell structure of mice in the model group is chaotic, swollen, and the cells are not arranged neatly, and there are lipid droplets in the gaps. After treatment with low, medium and high concentrations of solid microecological preparations, the morphology of liver cells tends to be normal, and the lipid droplets in the intercellular gaps are reduced, proving that the above-mentioned solid microecological preparations can effectively alleviate the acute damage to the liver caused by alcohol. The test results are shown in Table 7 below
[0175] Table 7 Effects of solid probiotic preparations on acute intoxication mouse model
[0176] Group Blank group Model Group Low concentration group Medium concentration group High concentration group Ethanol (mg / mL) <![CDATA[0.02±0.00 ** ]]> 4.67±0.47 <![CDATA[3.83±0.22 * ]]> <![CDATA[3.34±0.36 * ]]> <![CDATA[3.19±0.52 * ]]> Acetaldehyde (μg / mL) <![CDATA[2.88±0.34 ** ]]> 91.44±6.45 <![CDATA[81.38±3.68 * ]]> <![CDATA[81.62±5.51 * ]]> <![CDATA[74.75±4.86 * ]]> ADH (U / mg) <![CDATA[8.36±0.31 ** ]]> 6.62±0.79 16.64±0.69 <![CDATA[17.88±0.53 * ]]> <![CDATA[21.02±0.63 * ]]> ALDH (U / mg) <![CDATA[5.35±0.22 * ]]> 4.73±0.34 <![CDATA[8.65±0.66 * ]]> <![CDATA[11.73±0.58 * ]]> <![CDATA[11.56±0.83 * ]]> ALT(U / L) <![CDATA[16.41±3.36 ** ]]> 46.13±4.73 <![CDATA[36.52±6.14 * ]]> <![CDATA[38.73±5.22 * ]]> <![CDATA[33.63±6.89 * ]]> AST(U / L) <![CDATA[33.27±3.96 ** ]]> 60.10±5.23 <![CDATA[48.63±7.64 * ]]> <![CDATA[46.41±8.41 * ]]> <![CDATA[44.63±8.86 * ]]>
[0177] Note: *, significant difference (P<0.05); *, extremely significant difference (P<0.01); **.
[0178] The ethanol content in the blood can reflect the severity of alcohol poisoning. To a certain extent, the activity of ALD and ALDH enzymes is closely related to the metabolic rate of alcohol. As shown in Table 7, after mice drank alcohol, the ethanol content in the serum increased significantly, while after being treated with solid microecological preparations, the ethanol content and acetaldehyde content in the serum of mice decreased significantly, achieving the effect of sobering up and protecting the liver.
[0179] The levels of ALT and AST in the serum of mice with acute alcoholic liver injury are shown in Table 7. Compared with the blank group, the levels of ALT and AST in the serum of mice in the model group were significantly increased. At the same time, compared with the model group, the levels of ALT and AST in the serum of mice treated with solid probiotics were significantly decreased, which indicates that the use of solid probiotics to treat mice with acute alcoholic liver injury can reduce liver damage caused by alcohol and have a certain protective effect on the liver of mice.
[0180] 3. The sobering and liver-protecting effects of solid microecological preparations on the chronic drunkenness model in mice
[0181] 1) Experimental materials: SPF-grade healthy male C57BL / 6N mice, weighing approximately 20.00±2g / mouse, provided by the Experimental Animal Center of Ningbo University.
[0182] 2) Experimental plan: 20 mice were randomly divided into 4 groups, and the grouping was the same as that of the acute liver injury model, and the experiment lasted for 8 weeks. In the first week of the experiment, in order to adapt the mice to liquid food, each group of mice was fed with alcohol-free Lieber DeCarli liquid feed. Starting from the second week, except for the blank, the other groups were fed with ethanol-containing Lieber DeCarli liquid feed. The ethanol concentration in the feed increased by 1wt% every three days until the ethanol concentration in the feed reached 3.73% until the end of the experiment. During the experiment, each group of mice was gavaged at a fixed time every day, and the gavage conditions were the same as those of the acute liver injury model. After the last gavage of the mice, they were fasted but not watered for 12 hours, and serum and liver samples of the mice were collected. The levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the serum of the mice, alcohol dehydrogenase (ADH), acetaldehyde dehydrogenase (ALDH), malondialdehyde, and tumor necrosis factor-α (TNF-α) in the liver were determined using the kit, and the liver tissue of the mice was stained with HE. 16Sr RNA sequencing analysis was performed on the intestinal flora of mice to explore the effects of solid microecological preparations for alcohol detoxification and liver protection on the intestinal flora of mice.
[0183] 3) Experimental results: HE staining of mouse liver is as follows Fig.13 As shown by Fig.13 It can be seen that the nuclei of the liver cells of the blank group mice are clear and located in the center of the cells, the cells are tightly arranged, and the tissues are not edematous. The mice in the model group have severe liver damage characteristics, while the liver damage of the mice treated with solid microecological preparations is significantly reduced, the edema of the liver cells is reduced, the integrity is better, and the nuclei are clearly visible. The test results are shown in Table 8 below.
[0184] Table 8 Effects of solid probiotic preparations for alcohol detoxification and liver protection on the chronic drunkenness mouse model
[0185]
[0186]
[0187] Note: *, significant difference (P<0.05); **, extremely significant difference (P<0.01).
[0188] As shown in Table 8, after being treated with the solid microecological preparation for alcohol detoxification and liver protection, the activities of alcohol dehydrogenase and acetaldehyde dehydrogenase in mice with chronic liver damage can be significantly increased, reducing the damage to the liver caused by alcohol. It can also reduce the levels of ALT and AST in the serum of mice, indicating that the alcohol detoxification and liver protection Chinese medicine drink can reduce chronic liver damage caused by alcohol. In addition, the solid microecological preparation for alcohol detoxification and liver protection can also reduce the oxidative stress and inflammation levels of mice, and has an excellent protective effect on the liver of mice.
[0189] After being treated with the solid microecological preparation for alcohol detoxification and liver protection, the relative abundance bar graph of species at the genus level in the intestinal microorganisms of mice, such as Fig.14 The solid microecological preparation for alcohol detoxification and liver protection can increase the content of short-chain fatty acid and butyrate-producing bacteria in the intestines of mice, such as Pabacteroides, Alloprevotella, Paenalcaligenes, Monoglobus and Dubosiella, etc., improve the diversity of the mouse flora, and promote the colonization of beneficial bacteria in the intestines.
[0190] The above description is not intended to limit the present invention, and the present invention is not limited to the above examples. Any changes, modifications, additions or substitutions made by a person skilled in the art within the spirit and scope of the present invention shall also fall within the protection scope of the present invention.
Claims
1. A probiotic fermentation agent with alcohol sobering and liver protecting effects, characterized in that: The probiotic fermentation agent includes Lactobacillus rhamnosus ( Lacticaseibacillus rhamnosus ) MC-1 strain, Lactobacillus rhamnosus ( Lacticaseibacillus rhamnosus ) SSN-13 strain and Lactobacillus fermentans ( Limosilactobacillus fermentum ) G-1-46 strain, wherein the Lactobacillus rhamnosus ( Lacticaseibacillus rhamnosus ) MC-1 strain preservation number is CGMCC No: 27226, the rhamnosus lactobacillus ( Lacticaseibacillus rhamnosus ) The SSN-13 strain is deposited with CGMCC No: 27227, and the fermented mucus lactobacillus ( Limosilactobacillus fermentum ) G-1-46 strain preservation number is CGMCC No: 27225. The preparation method of the probiotic starter is as follows: Lactobacillus rhamnosus MC-1, Lactobacillus rhamnosus SSN-13 and fermented mucus lactobacillus G-1-46 are inoculated into a fermentation medium at a volume ratio of 5%, respectively, and cultured at 37°C for 18 hours to obtain a lactic acid bacteria culture. The lactic acid bacteria cultures of Lactobacillus rhamnosus MC-1, Lactobacillus rhamnosus SSN-13 and fermented mucus lactobacillus G-1-46 are mixed at a volume ratio of 1:1:
2. The fermentation medium is prepared by dissolving MRS medium with 1L of distilled water and sterilizing at 121°C for 15 minutes. The formula of the MRS medium is 10 grams of peptone, 10 grams of beef extract, 5 grams of yeast extract, 2 grams of diammonium citrate, 5 grams of sodium acetate, 20 grams of glucose, 80 milliliters of Tween, 0.5 grams of magnesium sulfate, 0.25 grams of manganese sulfate and 15 grams of agar powder.
2. A method for preparing a fermented Chinese medicinal drink having the function of sobering up and protecting the liver by using the probiotic fermentation agent according to claim 1, characterized in that The following steps are involved: (1) Preparation of Chinese herbal medicine extract: Weigh 15-20 g of Pueraria lobata flower, 20-25 g of Hovenia dulcis, 6 g of Atractylodes macrocephala, 6 g of Astragalus, 6 g of Lycium barbarum, 6 g of Dry ginger, 4.5 g of Poria, 6 g of Orientalis rhizome, 4.5 g of Ginseng, 3 g of Aucklandia lappa, 3 g of Citrus aurantium and 4.5 g of Citrus reticulata, and crush the herbs thoroughly with a wall-breaking machine and pass through an 80-mesh sieve; add ultrapure water 10 times the volume of the Chinese herbal medicine powder to soak the Chinese herbal medicine powder, decoct for 1 h, filter with gauze to remove large particles, centrifuge twice to obtain the supernatant, and sterilize at 121°C for 15 min to obtain the Chinese herbal medicine extract; (2) Fermentation: The probiotic fermentation agent of claim 1 is inoculated into the Chinese medicine extract obtained in step (1) at a volume ratio of 4%, and fermented at 37°C for 48 hours to obtain a fermented Chinese medicine drink with alcohol sobering and liver protecting functions.
3. A method for preparing a solid microecological preparation having the function of sobering up and protecting the liver by using the probiotic fermentation agent according to claim 1, characterized in that The following steps are involved: (1) Preparation of Chinese herbal medicine extract: Weigh 15-20 g of Pueraria lobata flower, 20-25 g of Hovenia dulcis, 6 g of Atractylodes macrocephala, 6 g of Astragalus, 6 g of Lycium barbarum, 6 g of Dry ginger, 4.5 g of Poria, 6 g of Orientalis rhizome, 4.5 g of Ginseng, 3 g of Aucklandia lappa, 3 g of Citrus aurantium and 4.5 g of Citrus reticulata, and crush the herbs thoroughly with a wall-breaking machine and pass through an 80-mesh sieve; add ultrapure water 10 times the volume of the Chinese herbal medicine powder to soak the Chinese herbal medicine powder, decoct for 1 h, filter with gauze to remove large particles, centrifuge twice to obtain the supernatant, and sterilize at 121°C for 15 min to obtain the Chinese herbal medicine extract; (2) Fermentation: inoculating the probiotic fermentation agent of claim 1 into the Chinese medicine extract obtained in step (1) at a volume ratio of 4%, and fermenting at 37°C for 48 hours to obtain a fermented Chinese medicine drink; (3) Preparation of lyophilized powder of fermented Chinese medicine: take the fermented Chinese medicine drink obtained in step (2), centrifuge it at 3000 rpm and 4°C for 15 min, take the supernatant and put it in a -80°C refrigerator for pre-freezing overnight, freeze-dry the pre-frozen sample at -49°C and 9 Pa for 48 h to obtain lyophilized powder of fermented Chinese medicine; (4) Preparation of lyophilized lactic acid bacteria powder: Take the lactic acid bacteria precipitate obtained after removing the supernatant in step (3) and adjust the bacterial concentration to 1×10 7 ~1×10 9 CFU / mL, centrifuge at 8000rpm and 4℃ for 15 min, take the precipitate and add a freeze-dried protective agent of the same volume as the fermented Chinese medicine drink, mix well and put into a -80℃ refrigerator for pre-freezing overnight, freeze-dry the pre-frozen sample at -49℃ and 9 Pa for 48h to obtain a freeze-dried lactic acid bacteria powder, wherein the freeze-dried protective agent formula is 118.2g / L trehalose, 17.1g / L L-cysteine, 10.3g / L sorbitol, 1.7g / L sodium acetate and 120g / L skim milk powder; (5) Preparation of solid probiotic preparation: The fermented Chinese medicine freeze-dried powder prepared in step (3) and the lactic acid bacteria freeze-dried powder prepared in step (4) are mixed in equal amounts to obtain a solid probiotic preparation having the function of sobering up and protecting the liver.
Citation Information
Patent Citations
Probiotics fermented Chinese herbal composition capable of dispelling effect of alcohol and protecting liver and preparing method and application thereof
CN106266105A
Probiotic and oligopeptide compound preparation with functions of dispelling effects of alcohol and protecting liver and preparation method
CN108208853A
Application of pueraria flower spleen-strengthening-relieving formula drug-containing serum in cancer cells
CN112263592A
Fermented milk powder and preparation method thereof
CN113180110A
Composition comprising grain-derived lactic acid bacteria for relieving hangover and bowel trouble
CN113924003A
